Insider Shareholders with Direct Ownership of Capricor Therapeutics, Inc. (CAPR)
This section provides a comprehensive overview of the insiders with direct ownership of Capricor Therapeutics, Inc. (CAPR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CAPRICOR THERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,798,507 | 0 | 7,090,351 $88.1 Million | 1 |
Sep 20, 2024
Added 28.3%
|
|
|
Linda Marban
CHIEF EXECUTIVE OFFICER |
45,749 | 12,500 | 211,104 $2.62 Million | 3 |
Mar 05, 2025
Reduced 5.59%
|
| 214,318 | 78,983 | 129,839 $1.61 Million | 8 |
Mar 03, 2025
Reduced 1.92%
|
|
| 104,791 | 45,990 | 81,692 $1.01 Million | 9 |
Aug 07, 2024
Added 29.39%
|
|
| 29,305 | 11,761 | 62,147 $771,865 | 4 |
Feb 21, 2023
Reduced 0.72%
|
|
| 57,606 | 0 | 57,606 $715,466 | 5 |
Feb 27, 2025
Added 1.29%
|
|
|
Karen Krasney
EVP, GENERAL COUNSEL |
26,932 | 0 | 28,047 $348,343 | 2 |
Dec 13, 2024
Added 22.19%
|
| 17,606 | 6,300 | 11,306 $140,420 | 4 |
Mar 03, 2025
Added 6.22%
|
|
|
Anthony Bergmann
CHIEF FINANCIAL OFFICER |
8,020 | 0 | 8,223 $102,129 | 3 |
Mar 03, 2025
Added 23.31%
|
| 5,000 | 0 | 5,000 $62,100 | 1 |
Oct 06, 2023
Added 50.0%
|
|
| 87,291 | 87,791 | 0 $0 | 6 |
Apr 17, 2023
Reduced 100.0%
|